{
    "nctId": "NCT06500494",
    "briefTitle": "To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment",
    "officialTitle": "Advanced Breast Cancer Patients Treated With Oral Vinorelbine: a Prospective and Retrospective, Observational Study - VINOREAL",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Advanced Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 368,
    "primaryOutcomeMeasure": "PFS rate in both cohorts.",
    "eligibilityCriteria": "Inclusion Criteria:\n\nFemale aged \u2265 18 years (\u2265 19 years for Algeria as per local regulation) at oral vinorelbine ( OV) -based treatment initiation\n\nConfirmed diagnosis of locally advanced or metastatic breast cancer eligible for chemotherapy\n\nInitiated OV-based treatment as per SmPC for advanced breast cancer between January 2011 and December 2020 for the retrospective cohort or, initiating oral vinorelbine treatment at enrollment for the prospective cohort\n\nWilling and able to complete the QoL questionnaire, PPQ and WPAI questionnaire for the prospective cohort\n\nProvision of informed consent or non-opposition to the patient (or next of kin/legal representative, if applicable) for the use of data, according to local regulations\n\nExclusion Criteria:\n\nno exclusion criteria for patients in this study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}